Historical changes in pneumococcal serogroup distribution: implications for the era of pneumococcal conjugate vaccines.
about
Controlling antimicrobial resistance through targeted, vaccine-induced replacement of strainsStreptococcus pneumoniae serotype-2 childhood meningitis in Bangladesh: a newly recognized pneumococcal infection threatContribution of vaccines to our understanding of pneumococcal disease.Efficacy of pneumococcal immunization in patients with renal disease--what is the data?High incidence of septic shock caused by Streptococcus pneumoniae serotype 3--a retrospective epidemiological studyPeriodic cycles of pneumococcal serotypes carried by children before and after 7-valent pneumococcal conjugate vaccine.Macrolide susceptibility and serotype specific macrolide resistance of invasive isolates of Streptococcus pneumoniae in Germany from 1992 to 2008Association of serotypes of Streptococcus pneumoniae with age in invasive pneumococcal disease.Temporal Variations among Invasive Pneumococcal Disease Serotypes in Children and Adults in Germany (1992-2008).Exposure to children as a risk factor for bacteremic pneumococcal disease: changes in the post-conjugate vaccine era.Invasive pneumococcal disease after implementation of 13-valent conjugate vaccine.Identification of invasive serotype 1 pneumococcal isolates that express nonhemolytic pneumolysin.Molecular epidemiology of penicillin-resistant and ciprofloxacin-resistant Streptococcus pneumoniae in Canada.Serotype-specific changes in invasive pneumococcal disease after pneumococcal conjugate vaccine introduction: a pooled analysis of multiple surveillance sites.Serotyping of Streptococcus pneumoniae based on capsular genes polymorphisms.Serotypes of Streptococcus pneumoniae isolates from children with invasive pneumococcal disease in Turkey: baseline evaluation of the introduction of the pneumococcal conjugate vaccine nationwide.Streptococcus pneumoniae from Palestinian nasopharyngeal carriers: serotype distribution and antimicrobial resistance.Paediatric community-acquired pneumonia: current concept in pharmacological control.Prediction of serotypes causing invasive pneumococcal disease in unvaccinated and vaccinated populations.Contribution of a response regulator to the virulence of Streptococcus pneumoniae is strain dependentDynamics of serotype 14 Streptococcus pneumoniae population causing acute respiratory infections among children in China (1997-2012)Vaccination Drives Changes in Metabolic and Virulence Profiles of Streptococcus pneumoniae.Genomics Reveals the Worldwide Distribution of Multidrug-Resistant Serotype 6E PneumococciPhenotypic analysis of pneumococcal polysaccharide-specific B cells.Pneumococcal serotypes in children in 4 European countriesPneumococcal vaccine development.Reduction of Streptococcus pneumoniae in upper respiratory tract cultures and a decreased incidence of related acute otitis media following introduction of childhood pneumococcal conjugate vaccines in a Swedish countyDecline in pneumococcal meningitis after the introduction of the heptavalent-pneumococcal conjugate vaccine in northern FranceThe multidrug-resistant PMEN1 pneumococcus is a paradigm for genetic success.Prevnar 7 Childhood Immunization Program and Serotype Replacement: Changes in Pneumococcal Incidence and Resulting Impact on Health Care Costs in Alberta (2003-2008).PCR-Based Serotyping of Streptococcus pneumoniae from Culture-Negative Specimens: Novel Primers for Detection of Serotypes within Serogroup 18Surveillance of pneumococcal diseases in Central and Eastern EuropeSerotype distribution of Streptococcus pneumoniae in children with invasive diseases in Turkey: 2008-2014Experience with pneumococcal conjugate vaccine in Norway.Observed differences in invasive pneumococcal disease epidemiology after routine infant vaccination.Streptococcus pneumoniae infection: a Canadian perspective.Antimicrobial Resistant Pattern and Capsular Typing of Streptococcus Pneumoniae Isolated from Children in Sistan -Baluchestan.Use of Pneumococcal Disease Epidemiology to Set Policy and Prevent Disease during 20 Years of the Emerging Infections ProgramVi antigen expression in Salmonella enterica serovar Typhi clinical isolates from Pakistan.Vaccine-induced human antibodies to PspA augment complement C3 deposition on Streptococcus pneumoniae.
P2860
Q28485487-62906751-FF79-4A1A-8C77-3B73E08FF273Q28730839-EFACC524-E9E1-47B3-A5B7-36959410964DQ30406750-3D3B661F-7C3B-4501-A833-3A2749250834Q30947054-C0934D05-D205-467D-A19C-6AD200BACB55Q33589823-078ECCCE-A294-4705-9610-88E9E2B38080Q33614566-F948ADEE-0DF7-4D26-8A78-0621E8D5EF79Q33756049-D656D957-28C0-46FE-81A0-1D5F8B8CB650Q33769670-834A9E10-9BBD-4024-9879-9E13DD15ACA9Q34021871-2A42DB60-63BE-4223-A254-98136C900715Q34157622-403C7C73-4FE0-4D86-99B8-F1BF25BC3A9AQ34296057-2B9B1527-F841-4DF1-B435-CB8E64BF26CDQ34315525-8A2D8DC9-8F57-4DEB-B92C-00ADAEFFDC2DQ34822980-966758C6-AF7B-4F82-A618-A9A147C41BBDQ35004396-B4FCF799-7C10-4C84-9070-297219BFFBCFQ35006235-18E4A851-3C62-4202-AE5F-F2C91B8FD866Q35066491-09C28F0B-CE4E-4A9D-BD56-B8524AC7AB31Q35067669-83548DAC-7AF0-428F-9495-4687CBDF0C58Q35124715-6ACA041B-CC5E-4999-80B5-A0CEAA18E6D4Q35124898-8DB5EAED-D547-47A9-B4E7-82443DA33948Q35165573-F28DBD8A-F2F2-42BA-9EED-23C92953E4E7Q35688602-C3FE3571-2FB8-4217-94E1-E0D47C2A0085Q35693577-A3BE9540-F33B-4A9F-AB91-481E915BC9BCQ35757571-1A8796C1-EFD7-49F7-A0C7-2288AF41AF45Q35784226-E7ACE010-DE85-43BF-BE11-99AC0885B928Q35806522-9D40F4B6-E5CE-4868-BA96-CFD952E7E357Q35918513-6AD90CF6-2232-495E-89E5-7AB28B91154EQ36101864-2EC0053D-B6B7-4354-BF89-FAB5888FA553Q36155052-F93AC155-79BB-4711-96C5-2611DCDF2A4BQ36633083-75C2691C-371E-45CF-8B4A-4B7CEF2E49DCQ36942824-E4F96EAA-AC06-4ADA-8426-6688C131F3D5Q37132048-CACD5296-E555-4641-8FA3-D34B4C4F7BA0Q37197020-AED85092-3470-4DA5-B3D8-AD32E1713A91Q37309254-8067E9AE-2E76-4115-B88A-FA24C2EF3236Q37386281-659C9785-0BC3-4473-B3AD-E7B11FFA5E97Q37844538-04688DA5-1A0C-472D-9B42-A1BFF66C5D73Q38131534-0B5C435A-2BAD-4231-83CE-B9C4127AD021Q38685133-1FDAFB09-8818-4E22-8690-06A085BA8C64Q41042487-72B82D83-F682-4D0F-BF39-47680FB9D366Q42722009-FC6A1C2C-2DFD-468B-B4DA-F906B2979DAEQ43078345-7F0C355C-CC52-4EF0-82EE-F16E6CC83FE5
P2860
Historical changes in pneumococcal serogroup distribution: implications for the era of pneumococcal conjugate vaccines.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Historical changes in pneumoco ...... eumococcal conjugate vaccines.
@en
Historical changes in pneumoco ...... eumococcal conjugate vaccines.
@nl
type
label
Historical changes in pneumoco ...... eumococcal conjugate vaccines.
@en
Historical changes in pneumoco ...... eumococcal conjugate vaccines.
@nl
prefLabel
Historical changes in pneumoco ...... eumococcal conjugate vaccines.
@en
Historical changes in pneumoco ...... eumococcal conjugate vaccines.
@nl
P2860
P356
P1476
Historical changes in pneumoco ...... eumococcal conjugate vaccines.
@en
P2860
P304
P356
10.1086/341896
P407
P577
2002-08-07T00:00:00Z